Clinical characteristics of two populations diagnosed of chronic obstructive pulmonary disease with GOLD spirometric criteria or by lower limit of normality;Características clínicas de dos poblaciones diagnosticadas de enfermedad pulmonar obstructiva crónica por criterios espirométricos GOLD o por el límite inferior de la normalidad

Revista de Patologia Respiratoria

Volumn 13, Issue 4, 2010, Pages 159-164

  Izquierdo, J L ^a   de Lucas, P ^b   Rodriguez J M ^b   Rodriguez J P ^a   Pons, S ^c  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c ESTEVE   (Spain)

Author keywords

COPD (chronic obstructive pulmonary disease); Diagnosis; GOLD; Lower limit of normality

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; CRITERION VARIABLE; DISEASE EXACERBATION; DYSPNEA; EMERGENCY HEALTH SERVICE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GOLD STANDARD; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; LOWER LIMIT OF NORMALITY; POPULATION RESEARCH; SPIROMETRY;

EID: 84864016774     PISSN: 15769895     EISSN: 2173920X     Source Type: Journal    
DOI: 10.1016/S1576-9895(10)34002-1     Document Type: Article

References (28)

1. Peces-Barba G., Barbera J.A., Agustí A., Casanova C., Casas A., Izquierdo J.L. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Arch Bronconeumol. 2008, 44:271-281.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. http://www.goldcopd.com.
3. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004, 23:932-946.
4. Celli B.R., Halbert R.J., Isonaka S., Schau B. Population impact of different definitions of airway obstruction. Eur Respir J. 2003, 22:268-273.
5. Roberts S.D., Farber M.O., Knox K.S., Phillips G.S., Bhatt N.Y., Mastronarde J.G. FEV1/FVC of 70% misclassifies patients with obstruction at the extremes of age. Chest. 2006, 130:200-206.
6. Hardie J.A., Buist A.S., Vollmer W.M., Ellingsen I., Bakke P.S., Mørkve O. Risk of overdiagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002, 20:1117-1122.
7. Enright P. Does screening for COPD by primary care physicians have the potential to cause more harm than good?. Chest. 2006, 129:833-834.
8. Mannino D.M., Buist S., Vollmer W.M. Chronic obstructive pulmonary disease in the older adult: What defines abnormal lung function?. Thorax. 2007, 62:237-241.
9. Pellegrino R., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R., et al. Interpretative strategies for lung function tests. Eur Respir J. 2005, 26:948-968.
10. Lucas-Ramos P., Izquierdo-Alonso J.L., Rodríguez-González Moro J.M., Bellón Cano J.M., Ancochea-Bermúdez J., Calle-Rubio M., et al. Asociación de factores de riesgo cardiovascular y EPOC. Resultados de un estudio epidemiológico (estudio ARCE). Arch Bronconeumol 2008, 238:233-238.
11. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin F., Yernault J.C., et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests European Community for Steel and Coal Official Statement of the European Respiratory Society. Eur Respir J. 1993, 6(Suppl 16):5-40.
12. Scanlon P.D., Connett J.E., Waller L.A., Altose M.D., Bailey W.C., Buist A.S. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000, 161:381-390.
13. Pinto-Plata V.M., Celli-Cruz R.A., Vassaux C., Torre-Bouscoulet L., Mendes A., Rassulo J., et al. Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society- Global Initiative for Chronic Obstructive Lung Disease stage categories and gender. Chest. 2007, 132:1204-1211.
14. Enright P.L. GOLD stage I is not a COPD risk factor Thorax. 2007, 62:1107-1109.
15. Roche N., Dalmay F., Pérez T., Kuntz C., Vergnenegre A., Neukirche F., et al. Impact of chronic airflow obstruction in a working population Eur Respir J. 2008, 31:1227-1233.
16. Ofir D., Laveneziana P., Webb K.A., Lam Y.M., O'Donnell D.E. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008, 177:622-629.
17. Vollmer W.M., Gislason P., Burney P., Enright P.L., Gulsvik A., Kocabas A., for the BOLD Collaborative Research Group, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J. 2009, 34:588-597.
18. Mannino D.M., Buist A.S., Volmer W.M. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?. Thorax. 2007, 62:237-241.
19. Pistolesi M., Camiciottoli G., Paoletti M., Marmai C., Lavorini F., Meoni E., et al. Identification of a predominant COPD phenotype in clinical practice. Respiratory Medicine. 2008, 102:367-376.
20. García-Aymerich J., Agustí A., Barbera J.A., Belda J., Farrero E., Ferrer A., et al. en nombre del Grupo de Trabajo sobre la Caracterización Fenotípica y Evolución de la Enfermedad Pulmonar Obstructiva Crónica (PAC-COPD). Phenotypic heterogeneity of chronic obstructive pulmonary disease. Arch Bronconeumol. 2009, 45:129-138.
21. Rennard S.I., Vestbo J. The Many "Small COPDs". COPD Should be an orphan disease. CHEST. 2008, 134:623-627.
22. Barr R.G., Celli B.R., Mannino D.M., Petty T., Rennard S.I., Sciurba F.C., et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med. 2009, 122:348-355.
23. Sin D.D., Anthonisen N.R., Soriano J.B., Agusti A.G. Mortality in COPD: Role of comorbidities. Eur Respir J. 2006, 28(6):1245-1257.
24. Fabbri L.M., Luppi F., Beghe B., Rabe K.F. Complex chronic comorbidities of COPD. 2008, 31:204-212.
25. Soriano J.B., Ancochea J., Miravitlles M., García-Río F., Durán E., Muñoz L., et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J 2009 Dec 8, [Epub ahead of print].
26. Punturieri A., Croxton T.L., Weinmann G.G., Kiley J.P. Chronic obstructive pulmonary disease: a view from the NHLBI. Am J Respir Crit Care Med. 2008, 178:441-443.
27. De Miguel Díez J., Izquierdo Alonso J.L., Molina Paris J., Bellón Cano J.M., Rodríguez González-Moro J.M., de Lucas Ramos P. Factors affecting drug prescription in patients with stable COPD: results from a multicenter Spanish study (IDENTEPOC). Arch Bronconeumol 2005, 41:63-70.
28. Izquierdo J.L., Barcina C., Jiménez J., Muñoz M., Leal M. Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract. 2009, 63:87-97.